Infectious complications of biologic treatments of rheumatoid arthritis

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

2002 • 4,076 citations

Exercise Capacity and Mortality among Men Referred for Exercise Testing

2002 • 3,819 citations

Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent

2001 • 3,631 citations

Anti-TNFα Therapy of Rheumatoid Arthritis: What Have We Learned?

2001 • 1,237 citations

Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin‐1 receptor antagonist, in combination with methotrexate: Results of a twenty‐four–week, multicenter, randomized, double‐blind, placebo‐controlled trial

2002 • 629 citations

Life‐threatening histoplasmosis complicating immunotherapy with tumor necrosis factor α antagonists infliximab and etanercept

2002 • 444 citations

Invasive Pulmonary Aspergillosis Associated with Infliximab Therapy

2001 • 332 citations

Tumor necrosis factor-α antagonists for the treatment of rheumatic diseases

2002 • 151 citations

Experience with etanercept in an academic medical center: Are infection rates increased?

2002 • 122 citations

Infliximab

2002 • 96 citations

Safety and Efficacy of Disease-Modifying Anti-Rheumatic Agents

2002 • 95 citations

COMORBIDITY IN RHEUMATOID ARTHRITIS

2001 • 91 citations

Listeria Meningitis After Treatment With Infliximab

2002 • 87 citations

Necrotising fasciitis in a patient receiving infliximab for rheumatoid arthritis

2002 • 84 citations

Disseminated cutaneous histoplasmosis in patients infected with human immunodeficiency virus

2002 • 82 citations

Disseminated cryptococcal infection in rheumatoid arthritis treated with methotrexate and infliximab.

2002 • 76 citations

Pulmonary miliary tuberculosis in a patient with anti-TNF-alpha treatment

2002 • 73 citations

Listeria infection during pregnancy: a 10 year experience.

2002 • 73 citations

Anti-TNF Therapy for Rheumatoid Arthritis and Other Inflammatory Diseases

2001 • 73 citations

Open label study to assess infliximab safety and timing of onset of clinical benefit among patients with rheumatoid arthritis.

2002 • 70 citations

Immunotherapy for rheumatoid arthritis

2001 • 69 citations

Exacerbation of mycobacterium tuberculosis enteritis masquerading as crohn’s disease after treatment with a tumor necrosis factor-α inhibitor

2002 • 47 citations

Emerging role of anti-tumor necrosis factor therapy in rheumatic diseases.

2002 • 45 citations

Anakinra Treatment of Patients with Rheumatoid Arthritis

2002 • 37 citations

Possible activation of an intramyocardial inflammatory process (Staphylococcus aureus) after treatment with infliximab in a boy with Crohn disease

2002 • 32 citations

Anticorps anti-TNFα (infliximab) et tuberculose :à propos de trois cas

2002 • 30 citations

Old and New Drugs Used in Rheumatoid Arthritis: A Historical Perspective

2001 • 23 citations

Meningitis in the neonate

2002 • 22 citations

Comparison of Host Resistance to Primary and SecondaryListeria monocytogenesInfections in Mice by Intranasal and Intravenous Routes

2002 • 20 citations

Effects of 2 Different Anti–Tumor Necrosis Factor–α Agents in a Primate Model of Subcutaneous Abscess Formation

2002 • 16 citations

[Fatal miliary tuberculosis during treatment with infliximab].

2002 • 10 citations

Pneumocystis carinii pneumonia in patients with and without HIV infection

2002 • 10 citations

Need for circumspection in prescribing tumor necrosis factor inhibitors and other biologic response modifiers

2002 • 7 citations

Anakinra Shows Promise for Treating Patients With Rheumatoid Arthritis

2002 • 7 citations

Cutaneous nocardiosis complicating Crohn?s disease management with infliximab

2001 • 4 citations

Using Anakinra for Adult Rheumatoid Arthritis

2002 • 2 citations